Emicizumab Prophylaxis in Hemophilia A with Inhibitors REPLY

被引：0
|
作者：
Oldenburg, Johannes [1 ]
Levy, Gallia G. [2 ]
机构：
[1] Univ Klinikum Bonn, Bonn, Germany
[2] Genentech Inc, San Francisco, CA 94080 USA
来源：
NEW ENGLAND JOURNAL OF MEDICINE | 2017年 / 377卷 / 22期
关键词：
BISPECIFIC ANTIBODY;
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：2194 / 2195
页数：2
相关论文
共 50 条
  • [1] Emicizumab Prophylaxis in Hemophilia A with Inhibitors
    Aledort, Louis M.
    Ewenstein, Bruce M.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2017, 377 (22): : 2193 - 2193
  • [2] Emicizumab Prophylaxis in Hemophilia A with Inhibitors
    Oldenburg, Johannes
    Mahlangu, Johnny N.
    Kim, Benjamin
    Schmitt, Christophe
    Callaghan, Michael U.
    Young, Guy
    Santagostino, Elena
    Kruse-Jarres, Rebecca
    Negrier, Claude
    Kessler, Craig
    Valente, Nancy
    Asikanius, Elina
    Levy, Gallia G.
    Windyga, Jerzy
    Shima, Midori
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2017, 377 (09): : 809 - 818
  • [3] ECONOMIC IMPACT OF EMICIZUMAB PROPHYLAXIS FOR HEMOPHILIA A WITH AND WITHOUT INHIBITORS
    Cortesi, P. A.
    Castaman, G.
    Mantovani, L. G.
    [J]. VALUE IN HEALTH, 2020, 23 : S699 - S699
  • [4] EMICIZUMAB PROPHYLAXIS IN PEOPLE WITH HEMOPHILIA A AND INHIBITORS: A SYSTEMATIC REVIEW
    Camelo, R.
    Prudente, T. P.
    Minare, D. V.
    Gomes, G. D. P. V. C.
    Roberti, M. D. R. F.
    [J]. HAEMOPHILIA, 2023, 29 : 53 - 54
  • [5] Emicizumab Prophylaxis in Patients with Hemophilia. with and without Inhibitors
    Ebbert, Patrick T.
    Xavier, Frederico
    Seaman, Craig D.
    Ragni, Margaret V.
    [J]. BLOOD, 2019, 134
  • [6] Emicizumab prophylaxis overcomes factor VIII inhibitors in Hemophilia A
    Shima, Midori
    [J]. JOURNAL OF PEDIATRICS, 2017, 190 : 289 - 289
  • [7] Management of Joint Replacement in Hemophilia a with Inhibitors during Emicizumab Prophylaxis
    Santagostino, Elena
    Mancuso, Maria Elisa
    Novembrino, Cristina
    Boscolo, Massimo Anzoletti
    Clerici, Marigrazia
    Pasta, Gianluigi
    Solimeno, Luigi Piero
    Peyvandi, Flora
    [J]. BLOOD, 2017, 130
  • [8] Emicizumab Prophylaxis in Patients Who Have Hemophilia A without Inhibitors
    Mahlangu, J.
    Oldenburg, J.
    Paz-Priel, I.
    Negrier, C.
    Niggli, M.
    Mancuso, M. E.
    Schmitt, C.
    Jimenez-Yuste, V.
    Kempton, C.
    Dhalluin, C.
    Callaghan, M. U.
    Bujan, W.
    Shima, M.
    Adamkewicz, J. I.
    Asikanius, E.
    Levy, G. G.
    Kruse-Jarres, R.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2018, 379 (09): : 811 - 822
  • [9] Emicizumab in Hemophilia A Reply
    Aledort, Louis M.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2020, 382 (08): : 786 - 786
  • [10] COST-EFFECTIVENESS OF EMICIZUMAB PROPHYLAXIS IN PATIENTS WITH HEMOPHILIA A WITHOUT INHIBITORS
    Olasupo, O.
    Matino, D.
    Iorio, A.
    Blackhouse, G.
    Xie, F.
    Tarride, J. E.
    [J]. VALUE IN HEALTH, 2022, 25 (07) : S428 - S428
12345